StockData
Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc. (KYMR) stock

KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/30227% above fair value
$121.52−4.33 (-3.44%)

Close on Nov 17, 2026Market cap $10.37BP/E –Yield –

Kymera Therapeutics cash

Cash and short-term investments held at the end of each period.

Kymera Therapeutics's cash was $971.21M at Sep 30, 2026. For fiscal 2025 it was $848.28M, up 73.6% from the year before. The highest annual figure on record is $848.28M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$848.28M+73.6%
FY2024Dec 31, 2024$488.74M+30.4%
FY2023Dec 31, 2023$374.88M-7.9%
FY2022Dec 31, 2022$407.17M-8.0%
FY2021Dec 31, 2021$442.42M+49.4%
FY2020Dec 31, 2020$296.20M+222.1%
FY2019Dec 31, 2019$91.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$971.21M+92.1%
Q2 FY2026Jun 30, 2026$690.99M+3.8%
Q1 FY2026Mar 31, 2026$650.93M+40.5%
Q4 FY2025Dec 31, 2025$848.28M+73.6%
Q3 FY2025Sep 30, 2025$505.68M-8.1%
Q2 FY2025Jun 30, 2025$665.45M+30.5%
Q1 FY2025Mar 31, 2025$463.15M-11.0%
Q4 FY2024Dec 31, 2024$488.74M+30.4%
Q3 FY2024Sep 30, 2024$549.97M+53.7%
Q2 FY2024Jun 30, 2024$509.95M+38.7%
Q1 FY2024Mar 31, 2024$520.54M+31.2%
Q4 FY2023Dec 31, 2023$374.88M-7.9%
Q3 FY2023Sep 30, 2023$357.83M-25.7%
Q2 FY2023Jun 30, 2023$367.57M-6.3%
Q1 FY2023Mar 31, 2023$396.88M-5.7%
Q4 FY2022Dec 31, 2022$407.17M-8.0%
Q3 FY2022Sep 30, 2022$481.91M-10.2%
Q2 FY2022Jun 30, 2022$392.31M+9.2%
Q1 FY2022Mar 31, 2022$420.81M+26.2%
Q4 FY2021Dec 31, 2021$442.42M+49.4%
Q3 FY2021Sep 30, 2021$536.39M+82.5%
Q2 FY2021Jun 30, 2021$359.11M+489.0%
Q1 FY2021Mar 31, 2021$333.54M+175.1%
Q4 FY2020Dec 31, 2020$296.20M+222.1%
Q3 FY2020Sep 30, 2020$293.84M+5403.7%
Q2 FY2020Jun 30, 2020$60.97M–
Q1 FY2020Mar 31, 2020$121.25M–
Q4 FY2019Dec 31, 2019$91.96M–
Q3 FY2019Sep 30, 2019$5.34M–

More Kymera Therapeutics figures

See a number that looks wrong?